Clinical Trial

A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 5, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is to evaluate the safety, tolerability, pharmacokinetics and efficacy of RSS0393 topical ointment in the treatment of plaque psoriasis in children and adolescents.
Trial Details
NCT Number NCT07102888
Lead Sponsor Jiangsu HengRui Medicine Co., Ltd.
Conditions Plaque Psoriasis in Children, Plaque Psoriasis in Adolescents
Enrollment 20 participants
Start Date 2025-08
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-08-05